Indian Generics Companies Change Course

Law360, New York (January 11, 2007, 12:00 AM EST) -- On the two-year anniversary of India’s revamped patent laws, generic drug makers in the country are shoring up their legal departments, boosting research and development, and setting their sights beyond national borders in a bid to beef up sales in the most lucrative pharmaceutical markets.

India has long been one of the world’s leading suppliers of generic drugs, but with the introduction of pharmaceutical patents in January 2005, the country’s top generic makers were forced to come up with a new business plan for survival....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.